Apr 28, 2020
Relmada Therapeutics Enhances Senior Leadership Team with Appointment of Brian A. Walter, Ph.D., as Vice President of Regulatory Affairs
Apr 21, 2020
Coleman Addiction Medicine Opens New Office in Fair Lawn, NJ
Apr 16, 2020
SUBLOCADE® Long-Term Safety Data Published in Journal of Clinical Psychopharmacology
Apr 02, 2020
BAART Programs Opens Outpatient, Opioid Addiction Treatment Programs in Bremerton & Port Angeles, Washington
Mar 31, 2020
Relmada Therapeutics Solidifies its R&D Leadership Team with the Appointment of Marc de Somer, MD, MBA, ScD, MPH, MSc, as Senior Vice President, Clinical Development and Safety
Mar 24, 2020
Relmada Therapeutics Strengthens Scientific Leadership Team with the Appointment of Judy Caron, Ph.D., as Vice President of Drug Development
Mar 23, 2020
Europe Pharmaceutical Drugs Market to Reach US$ 219.9 Billion by the End of 2027 - Coherent Market Insights
Feb 25, 2020
Medication Treatments Led to 80 Percent Lower Risk of Fatal Overdose for Patients with Opioid Use Disorder than Medication-free Treatments
Feb 25, 2020
Relmada Therapeutics to Present at 9th Annual SVB Leerink Global Healthcare Conference
Feb 13, 2020
Overuse of Opioids for Pain Relief Stimulates the Growth of Global Opioid Tolerance Treatment Market: Transparency Market Research
Jan 13, 2020
Baymark Health Services Opens Second Opioid Treatment Program In Columbus Ohio
Jan 10, 2020
Medicaid Expansion Associated with Fewer Total Opioid Overdose Deaths Across the U.S.
Jan 08, 2020
BayMark Health Services Opioid Treatment Programs Nationwide Now Accept Medicare
Jan 07, 2020
Q2i Awarded NIH/NIDA Grant to Develop and Evaluate Digital Technology to Improve Medication-Assisted Treatment in Primary Care
Jan 06, 2020
Original Medicare patients living with opioid use disorder are fully covered at all BHG Centers as of January 1, 2020
Dec 11, 2019
FDA issues warning letter for not including the most serious risks in advertisement for medication-assisted treatment drug
Dec 08, 2019
Computer Game May Help to Predict Reuse of Opioids
Oct 18, 2019
Global Opioid Overdose Pipeline Insights Report 2019
Oct 18, 2019
Spark Biomedical Receives $217K NIH Grant to Help Opioid-Addicted Newborns
Oct 14, 2019
Relmada Therapeutics to Announce Results of Phase 2 Study of REL-1017 for Treatment Resistant Depression and Conduct Conference Call on Tuesday, October 15